Submit comments to This email address is being protected from spambots. You need JavaScript enabled to view it. subject "Dose Rounding". All comments must be received by Friday, January 13, 2017.

Please focus your comments on the following areas:

  1. Should any content be added?
  2. Should any content be deleted?
  3. Will this document be useful for your practice?
  4. Do you think this document would be useful to a pharmacy that is implementing a dose rounding policy?
  5. Additional comments or suggestions (excluding spelling/grammar)

To submit your comments:

  1. Review the Dose Rounding of Cytotoxic Drugs and Monoclonal Antibodies Position Paper.
  2. Submit your comments to This email address is being protected from spambots. You need JavaScript enabled to view it. subject "Dose Rounding".

The comments must be received by Friday, January 13, 2017.